Dermata Therapeutics (DRMA) vs NuCana (NCNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Dermata Therapeutics is the larger company by market cap ($5.3 million vs $4.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | DRMA | NCNA |
|---|---|---|
| Share price | $1.07 | $1.13 |
| Market cap | $5.30M | $4.68M |
| 1-day change | -4.46% | -1.32% |
| EPS (TTM) | $-4.39 | $0.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.84 | $6.40 |
| 52-week low | $0.951 | $0.948 |
| Distance from 52-week high | -77.89% | -82.42% |
| Average volume | 708.18K | 123.99K |
| Shares outstanding | 4.96M | 4.16M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DRMA vs NCNA FAQ
Which is bigger, Dermata Therapeutics or NuCana?
Dermata Therapeutics (DRMA) is larger, with a market capitalization of $5.30M compared with $4.68M for NuCana (NCNA).
Are Dermata Therapeutics and NuCana in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.